Organoids Global Market Opportunities And Strategies To 2033
상품코드:1489302
리서치사:The Business Research Company
발행일:2024년 06월
페이지 정보:영문 309 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
세계의 오가노이드 시장은 2018년에 13억 605만 달러로 평가되며, 2023년까지 20.00% 이상의 CAGR로 성장했습니다.
맞춤형 의료에 대한 수요의 증가
맞춤형 의료에 대한 수요 증가는 오가노이드 시장의 성장을 가속했습니다. 맞춤의료는 정밀의료 또는 개인맞춤의료라고도 불리며, 환자 개개인의 특성에 맞는 치료와 개입을 목표로 하는 의료 접근법입니다. 환자 개개인의 특성을 재현할 수 있는 오가노이드는 특정 유전자 프로파일과 질병 특성에 맞는 치료를 위한 필수적인 툴이 되고 있습니다. 이러한 수요의 급증으로 약물 검사, 질병 모델링, 정밀의료 용도에서 오가노이드의 중요성과 채택이 증가하고 있습니다. 예를 들어 2022년 10월 미국 기반의 과학자, 환자 및 의료 서비스 프로바이더를 대표하는 단체인 Personalized Medicine Coalition은 여러 유형의 암, 유전적 희귀질환, 다양한 만성질환 및 감염성 질환을 앓고 있는 사람들을 위해 75,000개 이상의 유전자 검사 제품 및 300개 이상의 이상의 유전자 검사 제품과 300개 이상의 개인맞춤형 의약품이 시장에 나와 있는 것으로 추정하고 있습니다. 또한 개인맞춤형 의료를 옹호하는 미국 개인맞춤의료연합(PMC)에 따르면 2022년에는 미국 식품의약국(FDA) 신약 승인의 34%를 개인맞춤형 의약품이 차지할 것으로 추정되며, 지난 8년 동안 개인맞춤형 의약품은 승인 건수의 25% 이상을 차지했습니다. 따라서 맞춤형 의료에 대한 수요 증가는 지난 기간 중 유기체 시장의 성장을 지원했습니다.
목차
제1장 주요 요약
제2장 목차
제3장 표 리스트
제4장 도표 리스트
제5장 리포트 구성
제6장 시장의 특징
일반적인 시장의 정의
개요
오가노이드 시장 정의와 세분화
시장 세분화 : 제품별
간 오가노이드
대장 오가노이드
장관 오가노이드
기타
시장 세분화 : 용도별
발생생물학
감염증의 병리학
재생의료
약물 독성과 유효성 시험
Drug Discovery와 맞춤형 의료
기타
시장 세분화 : 최종 용도 산업별
병원으로 진단 센터
바이오의약품 기업
학술기관·연구기관
임상시험수탁기관(CRO)
시장 세분화 : 유래별
다능성 줄기세포
장기 특이적 성체 줄기세포
제7장 주요 시장 동향
바이오의약품 조사를 위한 오가노이드 솔루션에 초점을 맞추고, 솔루션을 확대
특수 3D 세포 모델의 작성을 위한 생명과학 조사의 진보
심장 안전성 시험의 개선을 향한 심장 오가노이드 기반 키트의 개발
차세대 오가노이드 기술의 진보를 향한 전략적 파트너십과 협업
하이스루풋(High throughput) 애플리케이션용 커스텀 오가노이드 라인 서비스에 주력
오가노이드와 세포 채취를 신속화하기 위한 3D 세포배양 기술의 채택 증가
제8장 오가노이드 시장 : 거시경제 시나리오
COVID-19의 영향 : 오가노이드 시장
우크라이나 전쟁의 영향 : 오가노이드 시장
고인플레이션의 영향 : 오가노이드 시장
제9장 세계 시장 규모와 성장
시장 규모
시장 성장 실적, 2018-2023
시장 촉진요인, 2018-2023
시장 억제요인, 2018-2023
시장 성장 예측, 2023-2028, 2033F
시장 촉진요인, 2023-2028
시장 억제요인, 2023-2028
제10장 세계의 오가노이드 시장 : 세분화
세계의 오가노이드 시장 : 제품별, 실적과 예측, 2018-2023, 2028F, 2033F
세계의 오가노이드 시장 : 용도별, 실적과 예측, 2018-2023, 2028F, 2033F
세계의 오가노이드 시장 : 최종 용도 산업별, 실적과 예측, 2018-2023, 2028F, 2033F
세계의 오가노이드 시장 : 유래별, 실적과 예측, 2018-2023, 2028F, 2033F
제11장 오가노이드 시장 : 지역·국가별 분석
세계의 오가노이드 시장 : 지역별, 실적과 예측, 2018-2023, 2028F, 2033F
세계의 오가노이드 시장 : 국가별, 실적과 예측, 2018-2023, 2028F, 2033F
제12장 아시아태평양 시장
제13장 서유럽 시장
제14장 동유럽 시장
제15장 북미 시장
제16장 남미 시장
제17장 중동 시장
제18장 아프리카 시장
제19장 경쟁 구도와 기업 개요
기업 개요
Thermo Fisher Scientific Inc
Carl Zeiss AG
Corning Incorporated
Lonza Group Ltd
STEMCELL Technologies Inc
제20장 경쟁 벤치마킹
제21장 경쟁 대시보드
제22장 주요 합병과 인수
Axosim Acquired The Microbrain-Associated Assets Of Vyant Bio's Stemonix Subsidiary
Bruker Corporation Acquired Acquifer Imaging
Molecular Devices Acquired Cellesce
Crown Bioscience International Acquired OcellO
제23장 기회와 전략
세계의 오가노이드 시장 : 새로운 기회를 제공하는 국가
세계의 오가노이드 시장 : 새로운 기회를 제공하는 부문
세계의 오가노이드 시장 : 성장 전략
제24장 오가노이드 시장 : 결론과 제안
결론
제안
제25장 부록
KSA
영문 목차
영문목차
Organoids are three-dimensional cell cultures that mimic the structural and functional characteristics of real organs. These miniature, simplified versions of organs are grown from stem cells in a laboratory environment to replicate some of the complex biological structures and processes of their full-sized counterparts.
The organoids market consists of sales, by entities (organizations, sole traders and partnerships), of organoids products that are a revolutionary tool in modern biomedical research and medicine, enabling scientists and doctors to study human development, disease progression and drug responses in a controlled and replicable way.
The global organoids market was valued at $1,306.05 million in 2018 which grew till 2023 at a compound annual growth rate (CAGR) of more than 20.00%.
Increase In Demand For Personalized Medicine
An increase in demand for personalized medicine propelled the growth of the organoids market. Personalized medicine, also known as precision medicine or individualized medicine, is an approach to medical care that aims to tailor treatments and interventions to the specific characteristics of each patient. Organoids, with their ability to replicate individual patient characteristics, have become indispensable tools in tailoring medical treatments to specific genetic profiles and disease characteristics. This demand surge has elevated the significance and adoption of organoids in drug testing, disease modeling and precision medicine applications. For instance, in October 2022, the Personalized Medicine Coalition, a US-based organization that represents scientists, patients and providers, promoting the understanding and adoption of personalized medicine to benefit patients and the healthcare system), estimated that more than 75,000 genetic testing products and 300 personalized medicines are on the market for people with multiple types of cancers, genetic rare diseases and a range of chronic and infectious diseases. Additionally, according to the Personalized Medicine Coalition (PMC), a US-based company that advocates for personalized medicine, personalized medicines were estimated to account for 34% of new drug approvals by the US Food and Drug Administration in 2022 and have accounted for at least 25% of approvals in each of the previous eight years. Therefore, the increase in demand for personalized medicine supported the growth of the organoids market during the historic period.
Advancements In Life Science Research For The Production Of Specialized 3D Cell Models
Companies are focusing on advancements in life science research for the production of specialized 3D organoids, representing a substantial stride in biomedical advancement. These pioneering advancements entail crafting organoids that closely emulate the structural and functional intricacies of human organs, granting researchers an unparalleled understanding of disease mechanisms and drug reactions. For example, in February 2024, Cell Microsystems, a US-based biotechnology company that provides advanced tools for cell biology, announced a strategic partnership with OMNI Life Science (OLS), a Germany-based cell biology company. This collaboration endeavors to launch three groundbreaking products-CERO, CASY and TIGR-into the US and Canadian markets, advancing life science research in North America. The CERO 3D, a pioneering instrument, fosters an ideal cell culture environment for producing specialized 3D cell models, such as stem cells, spheroids, organoids and tissues.
The global organoids market is fairly fragmented, with a large number of players operating in the market. The top ten competitors in the market made up to 17.50% of the total market in 2022.
Organoids Global Market Opportunities And Strategies To 2033 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global organoids market as it emerges from the COVID-19 shut down.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market research findings.
Benchmark performance against key competitors.
Utilize the relationships between key data sets for superior strategizing.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.
Where is the largest and fastest-growing market for organoids? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The organoids market global report from The Business Research Company answers all these questions and many more.
The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider organoids market; and compares it with other markets.
The report covers the following chapters
Introduction and Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by product, by application, by end-use industries and by source.
Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
Macro-Economic Scenario- The report provides an analysis of the impact of the COVID-19 pandemic, impact of the Russia-Ukraine war and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the organoids market.
Global Market Size And Growth- Global historic (2018-2023) and forecast (2023-2028, 2033F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
Regional And Country Analysis- Historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison by region and country.
Market Segmentation- Contains the market values (2018-2023) (2023-2028, 2033F) and analysis for each segment by product, by application, by end-use industries and by source in the market. Historic (2018-2023) and forecast (2023-2028) and (2028-2033) market values and growth and market share comparison by region market.
Regional Market Size and Growth- Regional market size (2023), historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
Competitive Dashboard- Briefs on competitive dashboard of major players.
Competitive Benchmarking -Briefs on the financials comparison between major players in the market.
Key Mergers and Acquisitions- Information on recent mergers and acquisitions in the market is covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
Conclusions And Recommendations- This section includes recommendations for organoids providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.
Markets Covered:
1) By Product: Hepatic Organoids; Colorectal Organoids; Intestinal Organoids; Other Organoids
2) By Application: Developmental Biology; Disease Pathology Of Infectious Disease; Regenerative Medicine; Drug Toxicity And Efficacy Testing; Drug Discovery And Personalized Medicine; Other Applications
3) By End-Use Industries: Hospitals And Diagnostic Centers; Biopharmaceutical Companies; Academics And Research Institutes; Contract Research Organizations
4) By Source: Pluripotent Stem Cells; Organ-Specific Adult Stem Cells
Companies Mentioned: Thermo Fisher Scientific Inc.; Carl Zeiss AG; Corning Incorporated; Lonza Group Ltd.; STEMCELL Technologies Inc.
Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; Italy; Spain; UK; Russia
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time-series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; organoids indicators comparison.
Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Table of Contents
1 Executive Summary
1.1 Organoids - Market Attractiveness And Macro Economic Landscape
2 Table Of Contents
3 List Of Tables
4 List Of Figures
5 Report Structure
6 Market Characteristics
6.1 General Market Definition
6.2 Summary
6.3 Organoids Market Definition And Segmentations
6.4 Market Segmentation By Product
6.4.1 Hepatic Organoids
6.4.2 Colorectal Organoids
6.4.3 Intestinal Organoids
6.4.4 Other Organoids
6.5 Market Segmentation By Application
6.5.1 Developmental Biology
6.5.2 Disease Pathology Of Infectious Disease
6.5.3 Regenerative Medicine
6.5.4 Drug Toxicity And Efficacy Testing
6.5.5 Drug Discovery And Personalized Medicine
6.5.6 Other Applications
6.6 Market Segmentation by End-Use Industries
6.6.1 Hospitals And Diagnostic Centers
6.6.2 Biopharmaceutical Companies
6.6.3 Academics and Research Institutes
6.6.4 Contract Research Organizations
6.7 Market Segmentation By Source
6.7.1 Pluripotent Stem Cells
6.7.2 Organ-Specific Adult Stem Cells
7 Major Market Trends
7.1 Focus On Organoid Solutions For Biotherapeutic Research And To Expand Solutions
7.2 Advancements In Life Science Research For The Production Of Specialized 3D Cell Models
7.3 Development Of Cardiac Organoids-Based Kits For Improved Cardiac Safety Testing
7.4 Strategic Partnerships And Collaborations To Advance Next-Generation Organoids Technology
7.5 Focus On Custom Organoid Line Services For High-Throughput Applications
7.6 Rising Adoption Of 3D Cell Culture Techniques To Expedite Organoid And Cell Harvesting
8 Organoids Market - Macro Economic Scenario
8.1 COVID-19 Impact On The Organoids Market
8.2 Impact Of The War In Ukraine On The Organoids Market
8.3 Impact Of High Inflation On The Organoids Market
9 Global Market Size and Growth
9.1 Market Size
9.2 Historic Market Growth, 2018 - 2023, Value ($ Million)
